Trastuzumab FDA Link

A humanized monoclonal antibody against the ERBB-2 RECEPTOR (HER2). As an ANTINEOPLASTIC AGENT, it is used to treat BREAST CANCER where HER2 is overexpressed.

Also Known As:

Herceptin; Trastuzumab qyyp; beta, Trastuzumab; Trastuzumab beta; Trastuzumab-qyyp; Trazimera

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Trastuzumab: 9058
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Trastuzumab: 9058
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Monoclonal Antibodies: 56412
        Humanized Monoclonal Antibodies: 217
        Trastuzumab: 9058

C Benkanoun Selected Research

C Benkanoun Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure